Status: current, Defined. Date: 30-Apr 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4687751000168111 | Adraprega (pregabalin 150 mg) capsule, 14 capsules, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4687761000168113 | Adraprega 150 mg capsule, 14, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Adraprega 150 mg capsule, 14, blister pack | Is a | Adraprega 150 mg capsule, 14 | true | Inferred relationship | Some | ||
| Adraprega 150 mg capsule, 14, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Adraprega 150 mg capsule, 14, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Adraprega 150 mg capsule, 14, blister pack | has TP | Adraprega | true | Inferred relationship | Some | ||
| Adraprega 150 mg capsule, 14, blister pack | has TPUU | Adraprega 150 mg capsule | true | Inferred relationship | Some | 54693021 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
New South Wales Reportable Schedule 4 medications reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Containered trade product pack reference set
FHIR